Based on the Solventum Corp. stock forecast from 6 analysts, the average analyst target price for Solventum Corp. is USD 71.81 over the next 12 months. Solventum Corp.’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Solventum Corp. is Bullish , which is based on 8 positive signals and 2 negative signals. At the last closing, Solventum Corp.’s stock price was USD 73.02. Solventum Corp.’s stock price has changed by -1.64% over the past week, -0.79% over the past month and 0% over the last year.
No recent analyst target price found for Solventum Corp.
No recent average analyst rating found for Solventum Corp.
Company Overview Solventum Corp.
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota. Read Less
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purifi...Read More
Frequently Asked Questions About Solventum Corp. (SOLV) Stock
Based on ratings from 6 analysts Solventum Corp.'s stock is Hold . Stock Target Advisor's fundamental analysis is Bullish . The stock has 1 buy, sell and 7 hold ratings.
Unfortunately we do not have enough data on SOLV's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for SOLV is USD 71.81 over the next 12 months. The maximum analyst target price is USD 82 while the minimum anlayst target price is USD 59.5.
SOLV stock's Price/Earning ratio is 198.16.
Our analysis grades SOLV stock's Price / Earning ratio at F. This means that SOLV stock's Price/Earning ratio is above 67% of the stocks in the Health Information Services sector in the NYE exchange.
Based on this SOLV may be a overvalued for its sector.
The last closing price of SOLV's stock was USD 73.02.
The most recent market capitalization for SOLV is USD 13.01B.
Based on targets from 6 analysts, the average taret price for SOLV is projected at USD 71.81 over the next 12 months.
This means that SOLV's stock price may go down by -1.65% over the next 12 months.
We can't find any ETFs which contains Solventum Corp.'s stock.
As per our most recent records Solventum Corp. has 0 Employees.
Solventum Corp.'s registered address is 3M Center, Saint Paul, MN, United States, 55144.
You can get more information about it from Solventum Corp.'s website at https://www.solventum.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Solventum Corp. (SOLV) Stock
Based on ratings from 6 analysts Solventum Corp.'s stock is Hold . Stock Target Advisor's fundamental analysis is Bullish . The stock has 1 buy, sell and 7 hold ratings.
Unfortunately we do not have enough data on SOLV's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for SOLV is USD 71.81 over the next 12 months. The maximum analyst target price is USD 82 while the minimum anlayst target price is USD 59.5.
SOLV stock's Price/Earning ratio is 198.16.
Our analysis grades SOLV stock's Price / Earning ratio at F. This means that SOLV stock's Price/Earning ratio is above 67% of the stocks in the Health Information Services sector in the NYE exchange.
Based on this SOLV may be a overvalued for its sector.
The last closing price of SOLV's stock was USD 73.02.
The most recent market capitalization for SOLV is USD 13.01B.
Based on targets from 6 analysts, the average taret price for SOLV is projected at USD 71.81 over the next 12 months.
This means that SOLV's stock price may go down by -1.65% over the next 12 months.
We can't find any ETFs which contains Solventum Corp.'s stock.
As per our most recent records Solventum Corp. has 0 Employees.
Solventum Corp.'s registered address is 3M Center, Saint Paul, MN, United States, 55144.
You can get more information about it from Solventum Corp.'s website at https://www.solventum.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SOLV !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
